89bio Inc (NASDAQ:ETNB) price on Wednesday, February 05, rose 8.47% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $11.66.
A look at the stock’s price movement, the close in the last trading session was $10.75, moving within a range at $10.7 and $11.84. The beta value (5-Year monthly) was 0.978. Turning to its 52-week performance, $16.63 and $5.99 were the 52-week high and 52-week low respectively. Overall, ETNB moved 46.48% over the past month.
89bio Inc’s market cap currently stands at around $1.70 billion, with investors looking forward to this quarter’s earnings report slated for in March.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ETNB is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
8 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 7 recommend ETNB as a Buy and 1 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ETNB’s current price about 47.98% and 44.88% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 78.39, while 7-day volatility ratio is 9.44% and 9.50% in the 30-day chart. Further, 89bio Inc (ETNB) has a beta value of 1.33, and an average true range (ATR) of 0.88. Analysts have given the company’s stock an average 52-week price target of $12, forecast between a low of $12 and high of $12. Looking at the price targets, the low is -2.92% off current price level while to achieve the yearly target high, price needs to move -2.92%. Nonetheless, investors will most likely welcome a -2.92% jump to $12 which is the analysts’ median price.
If we refocus on 89bio Inc (NASDAQ:ETNB), historical trading data shows that trading volumes averaged 6.26 over the past 10 days and 1.96 million over the past 3 months. The company’s latest data on shares outstanding shows there are 117.58 million shares.
The 4.21% of 89bio Inc’s shares are in the hands of company insiders while institutional holders own 97.48% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 8.35 million on 2025-01-15, giving us a short ratio of 6.81. The data shows that as of 2025-01-15 short interest in 89bio Inc (ETNB) stood at 888.0000000000001 of shares outstanding, with shares short rising to 6.94 million registered in 2024-12-13. Current price change has pushed the stock 49.10% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ETNB stock continues to rise going into the next quarter.
